phenylalanine has been researched along with Lower Extremity Weakness, Spastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blau, N; Casaer, P; Goriounov, D; Hedrich, K; Klein, C; Legius, E; Matthijs, G; Møller, LB; Romstad, A; Steyaert, J; Theys, P; Van Hove, JL; Wevers, R | 1 |
Jinnah, HA; Kasim, S; Moo, LR; Zschocke, J | 1 |
2 other study(ies) available for phenylalanine and Lower Extremity Weakness, Spastic
Article | Year |
---|---|
Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency.
Topics: Adolescent; Adult; Circadian Rhythm; Dystonia; Female; Fibroblasts; Gene Expression; GTP Cyclohydrolase; Humans; Lower Extremity; Male; Middle Aged; Paraparesis, Spastic; Parkinsonian Disorders; Pedigree; Phenotype; Phenylalanine; Polymerase Chain Reaction; Reflex, Abnormal; Syndrome; Tendinopathy; Tremor | 2006 |
Phenylketonuria presenting in adulthood as progressive spastic paraparesis with dementia.
Topics: Age of Onset; Cognition; Dementia; Diagnosis, Differential; Diet, Protein-Restricted; Disease Progression; Female; Gait; Genotype; Humans; Magnetic Resonance Imaging; Middle Aged; Mutation; Neuropsychological Tests; Paraparesis, Spastic; Phenotype; Phenylalanine; Phenylketonurias; Treatment Outcome | 2001 |